3 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Philip Dutton of Solidatus, Benjamin Foster of Nurseify, and Tasos Katsaounis of Bread Man Baking Co. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from baking to software development — recently making headlines in Houston innovation.

Philip Dutton, CEO of Solidatus

Philip Dutton is the new Houston-based CEO of Solidatus, a London-founded data management startup. Photo via LinkedIn

As part of a company reorganization, data management startup Solidatus has established Houston as its North American headquarters and has named co-founder Philip Dutton as its Houston-based CEO.

Founded in London in 2017, Solidatus initially focused on supplying data management software to businesses in Europe, the Middle East, and Africa, but has since extended its reach to North America. Overall, Solidatus employs more than 110 people. It plans to triple its U.S. headcount over the next year.

“Solidatus serves visionary organizations that desire streamlined access and clarity of their data to build smarter and more profitable businesses. That’s everyone from Fortune 500 companies that have an unmanageably complex data landscape to startups and scale-ups that want to optimize their data practices from the get-go. There is no greater concentration of these organizations than in the U.S.,” Dutton, who had been the co-CEO, says in a news release. Click here to read more.

Benjamin Foster, founder and CEO of Nurseify

Benjamin Foster was leading human resources at Gulf Coast Division during Hurricane Harvey when he saw a huge need for an alternative to hiring short-term nurses quickly. That's when he had the idea for Nurseify, a platform that allows for nurses to find jobs — and for facilities to find nurses with the specialties they need. The platform is now live in five pilot states — Texas, Georgia, Florida, South Carolina, and Nevada.

Nurses are facing a significant amount of burnout — in part due to what they went through during the pandemic, but also because of the stressful work environments due to hiring misalignment. Foster says he's intentionally designed the platform to be supportive of nurses.

"We want Nurseify to be known as the most nurse-friendly company in the world. We believe we can bridge the gap between administration and operations and nurses," Foster says. "We want 'Nurseify' to become a verb at some point." Click here to read more.

Tasos Katsaounis, CEO and founder of Bread Man Baking Co.

How Tasos Katsaounis took his hobby and let it rise into a booming Houston business. Image via breadmanco.com

Four years ago, while looking to escape the daily rigors of his corporate work stress, Houstonian Tasos Katsaounis began to bake bread between Zoom calls. He took that hobby and turned it into Bread Man Baking Co. – a Houston-based artisan bread business that can now be tasted in restaurants all throughout the city.

“You know, there’s just something about the idea of growing something from nothing,” Katsaounis, CEO and founder of the company, tells InnovationMap. “I really feel like for the first time in my 26 years of working professionally, that I'm doing what I'm supposed to be doing and I'm super passionate about what I do every day.”

At the end of 2021, the company expanded from its 5,000-square-foot kitchen and moved its operations into a new 40,000-square-foot facility on the northeast side of Houston, close to the Budweiser and Kroger distribution buildings. At the time of the move, it had 17 employees and this year it has since grown to 42. Click here to read more.

Philip Dutton is the new Houston-based CEO of Solidatus, a London-founded data management startup. Photo via LinkedIn

London-based data management tech firm announces new Houston HQ, CEO

new to hou

As part of a company reorganization, data management startup Solidatus has established Houston as its North American headquarters and has named co-founder Philip Dutton as its Houston-based CEO.

Dutton had shared co-CEO duties with the other co-founder, Philip Miller. Miller now holds the newly created role of chief innovation officer.

“We are extremely pleased that Solidatus chose Houston as their North American headquarters," says Susan Davenport, chief economic development officer of the Greater Houston Partnership. "Solidatus’ announcement solidifies the region’s position as a top U.S. metro for business relocations and expansions due to its global connectivity and access to a well-developed suite of key global industries, including energy, life sciences, and aerospace.”

Sheldon Feinland, the company’s newly installed New York City-based vice president of global sales, says year-over-year growth of 300 percent in North America is “well within our grasp.” The startup’s customers are in the financial services, health care, insurance, retail, manufacturing, and government sectors.

“We’re focused on creating unique solutions that untangle the messy world of data,” Feinland says. “This way, data becomes easier to work with, and we can maximize the potential of the organizations that house it.”

In 2021, Solidatus raised $19.2 million in a Series A funding round led by AlbionVC with participation from two customers, Citi and HSBC. Much of that money is being spent on the company’s North American expansion.

“We are at a point in the company’s progress and diversification across industries when new ideas are at an all-time premium. Now is absolutely the best time to take on this important new role,” Miller says.

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

2024 Google search volume for terms related to investing
Number of investors
Number of businesses receiving investments in 2024
Total amount of capital invested in businesses in 2024
Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME